Trials / Unknown
UnknownNCT01184599
A Prospective Study of the Kidney Protective Effect of Aliskiren in Hypertensive Patients With IgA Nephropathy
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Kagawa University · Academic / Other
- Sex
- All
- Age
- 16 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effect of aliskiren, a novel direct rennin inhibitor, on renal function and progress of renal disease in hypertensive patients with IgA nephropathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | aliskiren | 150 mg/day p.o. |
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2013-03-01
- First posted
- 2010-08-19
- Last updated
- 2011-06-27
Locations
4 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01184599. Inclusion in this directory is not an endorsement.